Pakistan joins 52 countries on Covid-19 research, development

Published August 27, 2021
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. —  AFP/File
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. — AFP/File

ISLAMABAD: Pakistan has enrolled to participate in the ‘Solidarity PLUS’ clinical trial led by the World Health Organisation (WHO) that will evaluate three potential drugs — artesunate, imatinib and infliximab — for the treatment of Covid-19 infections aiming to protect people from severe hospitalisation and death because of the pandemic.

WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study, making up the largest global collaboration on Covid-19 research and development.

The three potential drugs were selected by a panel of experts who assess all available evidence on relevant therapeutics. The drugs have proven effectiveness in treating other life-threatening diseases. Artesunate is used for severe malaria, imatinib for specific cancers, and infliximab for diseases of the immune system, such as Crohn’s disease and rheumatoid arthritis.

“Covid-19 has been the most disruptive public health challenge in the past century. In less than two years, the pandemic has claimed over 4.4 million lives across the world, overwhelmed health systems, and disrupted economies and societies.

“It is critical that we find effective treatments to prevent severe hospitalisation and death caused by Covid-19. We appreciate the efforts of countries in the region in collaborating on vital global studies for the treatment of Covid-19, in the spirit of solidarity,” said Dr Ahmed Al-Mandhari, WHO Regi­onal Director for the Eastern Mediterranean.

Published in Dawn, August 27th, 2021

Opinion

Editorial

IMF scrutiny
Updated 11 Feb, 2025

IMF scrutiny

Strengthening foundations of the economic superstructure will help make the economy competitive and boost growth.
Shadow voices
11 Feb, 2025

Shadow voices

OVER the weekend, another ‘open letter’ addressed to the army chief and attributed to former prime minister ...
Paradise at a premium
11 Feb, 2025

Paradise at a premium

PAKISTAN’S recent triumph at the New York Travel and Adventure Show 2025, winning the Best Partner Pavilion Award,...
A positive note
Updated 10 Feb, 2025

A positive note

With govt unable to press growth accelerator without upending fragile recovery, sufferings of low-middle-income households are unlikely to disappear soon.
Justice for all
10 Feb, 2025

Justice for all

ALONG with his domestic agenda, Donald Trump is busy ripping to shreds the post-World War II ‘rules-based...
Held back
10 Feb, 2025

Held back

IT is a crying shame how women are conspicuously absent from Pakistan’s civil services. Despite comprising half ...